INTRODUCTION
Cutaneous tuberculosis (TBC) is a chronic disease caused by Mycobacterium tuberculosis and occurs in less than 2% of all cases of extrapulmonary TBC, with an incidence of 0.5-0.6%, and an estimated association between cutaneous and visceral TBC of 28% of all cases [1] . It can appear as a manifestation of a systemic infection, although it can also exist as primary cutaneous TBC [1, 2] . The most frequent forms are scrofuloderma and lupus vulgaris [3, 4] . Clinical manifestations of cutaneous TBC can be classified by their dissemination in endogenous and exogenous infections [5] , and according to local bacterial concentrations in multibacillary (high bacillary concentration) and paucibacillary (low bacillary concentration) lesions [4] , in which extreme tuberculids are found [6] . Multibacillary forms can be caused by direct inoculation (tuberculous chancre), by continuity (scrofuloderma, periorificial cutaneous tuberculosis), or by hematogenous spread (acute miliary tuberculosis and tuberculous gumma), while the paucibacillary forms of cutaneous TBC can be produced by direct inoculation (tuberculosis verrucosa cutis, lupus vulgaris in some cases, and tuberculids) or by hematogenous dissemination (lupus vulgaris and tuberculids) [5] . In the case of multibacillary forms, cultures and stains like Ziehl-Neelsen usually show positive results for M. tuberculosis, confirming diagnosis by this way [2, 4, 6] . However, in paucibacillary forms, due to the low bacillar concentration found locally in lesions, tests for bacillus may be negative. The actual problem of diagnosis in cutaneous TBC is therefore the demonstration of bacillus in skin biopsies, particularly in paucibacillary forms. This has forced use of new diagnostic resources, and polymerase chain reaction (PCR) has improved global diagnostic accuracy [7] [8] [9] .
In this article, two cases of cutaneous TBC with histopathology of tuberculid and rosaceiform lesions are presented; both cases were diagnosed using PCR. In addition, a brief literature review will discuss reconsidering Lewandowsky's rosaceiform eruption [10, 11] once again into the spectrum of cutaneous TBC.
CASE PRESENTATION

Case 1
A 52-year-old Chilean woman presented with facial erythematous papulo-nodular and pruriginous lesions which first occurred 4 months previously in both glabellar regions.
These legions extended progressively to the rest of the face, with confluence zones and an association with scratching ( Fig. 1) . She had no relevant medical history or contact with patients with known TBC, and had been vaccinated with Bacillus Calmette-Guérin (BCG) after birth. She had been previously treated for 3 months for acne rosacea using different drug therapies (oral doxycycline 100 mg every 12 h, followed by oral isotretinoin 20 mg per day, and topical treatment with alpha-bisabolol 1% and metronidazole gel 1%) with partial response. Because of these findings, cutaneous TBC was suspected, and so PCR for M. tuberculosis was requested. PCR technique was done using amplification in duplicate for sequence IS6110 [specific for Mycobacterium tuberculosis complex (MTC)] [12] . Evaluation of DNA's integrity from the sample was performed by amplification of human beta-globin gene (positive internal control) and a water-only sample (H 2 O), to discard the possibility of contamination (negative external control) [13] (cytology and histopathology laboratory, Catholic University health network). PCR result was positive for TBC ( [12] . At the same time, DNA integrity of the skin sample was evaluated by amplification of the human beta-globin gene (positive internal control) and a water-only sample (H 2 O) to discard the possibility of contamination (negative external control) [13] . (Fig. 7) .
Tests for the primary focus did not show the presence of TBC.
Informed consent was obtained from all patients for being included in the study.
DISCUSSION
Prevalence of TBC in Chile has diminished during the last few decades, reaching a rate of 13.3/100,000 in 2006 [15] . However, with the recent outbreak of human immunodeficiency virus (HIV), the use of novel immunosuppressive drug therapies, the emergence of multidrug-resistant TBC strains, and migrations of population, the current context may change [5, 16] . This situation is particularly reflected in HIV and acquired immune deficiency syndrome (AIDS) patients, in whom prevalence of TBC is significantly higher than in the general population [17] .
Cases of extrapulmonary TBC are usually more difficult to diagnose [18] . This is particularly relevant in paucibacillary forms of cutaneous TBC, where tests for bacillus may be negative. At immune-mediated mechanisms [20] . More often, cutaneous symptoms have appeared during treatment of pulmonary TBC as tuberculosis-associated adverse drug reactions [21] . In our report, the first patient presented pruriginous lesions. Although rare, pruritus has been described in cases of tuberculids, especially in papulonecrotic tuberculids [22] [23] [24] [25] . Immune mechanisms are yet to be understood, but several authors have proposed that tuberculids (erythema induratum of Bazin, papulonecrotic tuberculid) represent delayed-type IV hypersensitivity reactions mediated by antigen-specific effector T cells [26] [27] [28] . In this immune reaction, symptoms such as itching are associated with increased production and release of cytokines, neurotrophins and neuropeptides, and are regulated by infiltrating tissue resident cells [29] . Cytokines and chemokines are inflammatory mediators and important activators of sensory nerves, thereby contributing to neurogenic inflammation, pain and pruritus [30] . Recent findings have identified potential classes of endogenous ''itch mediators'' and established a modern concept for the pathophysiology of pruritus [29, 31] .
Due to its low bacillary concentration, it has been discussed whether to define tuberculids as produced by the presence of the bacillus in the skin, or if it is produced by hypersensitivity reactions [11] . Lewandowsky described in 1917 a clinical form that he called Lewandowsky's rosaceiform tuberculid [10] , considered initially inside the spectrum of tuberculids [32] [33] [34] [35] ; however, this was later criticized by authors like Snapp et al. [11] , because of the impossibility to isolate microorganisms in skin samples, and also for failing to show hypersensitivity to tuberculin. These same authors suggested in those years that it might be a new clinical entity by itself, or a variation of papular rosacea with tuberculoid histopathology, rather than a clinical manifestation of TBC. Because of this, it stopped being considered as part of tuberculids and cutaneous TBC, and was later renamed as Lewandowsky's rosaceiform eruption, also called lupus miliaris disseminatus faciei (LMDF), acne agminata, and acnitis [36] [37] [38] [39] . Through the years, in many reports lupus miliaris disseminatus faciei/Lewandowsky eruption has been related to TBC, sarcoidosis and rosacea [38] [39] [40] [41] , with four different histopathological forms previously defined (for LMDF) [41] . It is important to outline that studies that dismissed Lewandowsky's eruption as a form of TBC did not use the same technology that is now used for diagnostic purposes. This scenario might actually change thanks to the new diagnostic techniques available, such as amplification of DNA from M. tuberculosis with PCR. In a number of studies [7] [8] [9] , PCR has been shown to be the best diagnostic alternative when laboratory tests (e.g., immunohistopathology, Ziehl-Neelsen stains, Kinyoun, fluorochromic techniques using Auramine-Rhodamine for acid-alcoholresistant bacillus, cultures, and detection of INFgamma with QuantiFERON, and ELISpot with ELISA) are not suitable for diagnosis. PCR has been reported to have a global sensitivity up to 88% and specificity of 83% for the diagnosis of cutaneous TBC [7] , but the accuracy of PCR varies depending on a number of factors such as geographic region, local bacterial concentrations and the DNA amplification technique used for PCR [6, 19, 42] . Some investigations have reported false negative results that might be explained by variations in the insertion sequence 6110 (IS6110) in strains of MTC, and because of a low copy number of IS6110 in M. tuberculosis strains described in some regions of the world [43] .
PCR with hybridization for DNA amplification seems to be a good option because of the advantage that it offers in the reduction of false negatives [44] . 
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